Advertisement
Новости Форекс
Pound Spikes Up Against Majors
The pound moved up against its major counterparts in the European session on Monday.
RTTNews |
542 дней спустя
Quoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003
Quoin Pharmaceuticals Ltd. (QNRX) announced Monday that the U.S. Food and Drug Administration (FDA) has cleared the recruitment of teen subjects aged 14 years and older into its two ongoing clinical trials for QRX003, which is being developed as a potential treatment for Netherton Syndrome (NS).
RTTNews
|
542 дней спустя
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March
Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews
|
542 дней спустя
Japan Govt Mulls Declaring End To Deflation - Kyodo
The Japanese government has began discussions over officially declaring an end to deflation, news agency Kyodo reported over the weekend, citing sources close to the matter. For this, the government will carefully examine the outcome of wage negotiations this spring and the inflation outlook, the report said.
RTTNews
|
542 дней спустя
Cerence Appoints Daniel Tempesta To Succeed Tom Beaudoin As CFO
Cerence Inc. (CRNC) announced Monday that it has appointed Daniel Tempesta as its new Chief Financial Officer (CFO), effective March 18, 2024. Tempesta replaces Tom Beaudoin, who has served on Cerence's Board of Directors since October 2019 and as Cerence's CFO since May 2022.
RTTNews
|
542 дней спустя
NeuroBo Pharmaceuticals Confirms Marshall Woodworth As New CFO
Biotechnology company NeuroBo Pharmaceuticals, Inc. (NRBO) announced Monday the appointment of Marshall Woodworth as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 1, 2024, following his tenure as Acting Chief Financial Officer since October 27, 2023.
RTTNews
|
542 дней спустя
Eurozone Investor Confidence Rises For Fifth Month
Eurozone investor confidence improved for the fifth straight month to a one-year high in March but remained negative indicating that a spring revival would probably be an exaggeration, survey data published by the behavioral research institute Sentix showed Monday.
RTTNews
|
542 дней спустя
more news
EU Fines Apple Over EUR 1.8 Bln For Abusive App Store Rules
The European Commission said fined Apple Inc. over 1.8 billion euros for abusing its dominant position through its App Store on the market for the distribution of music streaming apps to iPhone and iPad users or iOS users. In pre-market activity on Nasdaq, Apple shares were losing around 1.3 percent.
RTTNews
|
542 дней спустя
Zevra Therapeutics Says FDA Extends NDA Review Period For Arimoclomol
Zevra Therapeutics, Inc. (ZVRA) announced Monday the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for arimoclomol, an investigational orally delivered, first-in-class treatment for Niemann-Pick disease type C (NPC).
RTTNews
|
542 дней спустя
Powell Testimony, Jobs Report Likely To Be In Focus This Week
While the U.S. economic calendar starts the week off relatively quiet, several key events are likely to attract attention in the coming days.
Federal Reserve Chair Jerome Powell's congressional testimony is likely to be in focus, as investors on Wall Street analyze the central bank chief's comments for clues about the outlook for interest rates.
RTTNews
|
542 дней спустя
Dollar Drops In A Week Of Divergent Inflation Trends
Inflation trends mattered much to currency markets during the period spanning February 24 to March 1, 2024. The week witnessed the U.S. Dollar weakening against the Euro as well as the Japanese Yen but strengthening against the British Pound and the Australian Dollar amidst divergent inflation trends.
RTTNews
|
542 дней спустя
EDAP TMS Says FDA Grants Breakthrough Designation To Focal One For Rectal Endometriosis
EDAP TMS SA (EDAP) announced Monday that its Focal One platform has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA) for the treatment of deep infiltrating endometriosis (DIE).
RTTNews
|
542 дней спустя
Vista Outdoor Rejects Unsolicited Indication Of Interest From MNC Capital Of $35/share In Cash
Vista Outdoor Inc. (VSTO) announced Monday that its Board of Directors, following consultation with its financial and legal advisors, has rejected an unsolicited indication of interest received on February 19, 2024 from MNC Capital.
RTTNews
|
542 дней спустя
Stay up to date!
Add Новости to your browser
Add To Chrome
